STAT3 and hepatocellular carcinoma: In the current study, by performing the public data analysis and combined with our experimental results, it is shown that FAM134B overexpression significantly repressed JAK2/STAT3 activity but inhibiting of FAM134B significantly increase JAK2/STAT3 activity in HCC.